Drug Overview Incruse (umeclidinium; GlaxoSmithKline) is a once-daily long-acting muscarinic antagonist (LAMA) indicated for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). Incruse received US and EU approvals for use in COPD in April 2014. GlaxoSmithKline has also developed umeclidinium in combination with the long-acting beta 2 agonist (LABA) vilanterol; the LABA/LAMA combination is marketed under the brand name Anoro.
Our reports have been used by over 10K customers, including:
The major factors attributing to the growth of the biosurgery market are increasing geriatric population, rising prevalence of chronic diseases and related surgeries, and a strong focus on R&D leading to the launch of new and advanced products. The global increase in the number of geriatrics population and obese people is likely to...
The Asia Pacific Spirometer Market would witness market growth of 12.1% CAGR during the forecast period (2020-2026). Portable spirometers have been becoming popular as they are compact and lightweight. Furthermore, these devices can store many diagnostic test results and can print the results on traditional printers. In addition, results...
Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-infective, Chemotherapy), By Region, And Segment Forecasts, 2021 - 2028 Home Infusion Therapy Market Growth & Trends The global home infusion therapy market...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the erythropoietin (EPO) market are Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc and LG Life Sciences Ltd. The global erythropoietin (EPO) market is expected to decline from $1.01 billion in 2019 to $0.95 billion in 2020 at a compound annual growth rate (CAGR) of -6.27%. The decline...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the protein inhibitors market are Bayer AG, Astra Zeneca, Roche, Teva, Apotex, Novartis, GlaxoSmithKline, Pfizer, Boehringer Ingelheim and F. Hoffmann-La Roche. The global protein inhibitors market is expected to decline from $59.66 billion in 2019 to $56.97 billion in 2020 at a compound annual growth rate (CAGR) of...
The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025. Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, rising preference for self-administration of drugs, usability advantages,...
India Ventilator Market, By Equipment Type (Invasive Ventilation v/s Non-Invasive Ventilation), By Product Type (Adult/Pediatric v/s Neonatal/Infants), By Mobility (Standalone v/s Portable), By Mode (Combined Mode, Volume Mode, Pressure Mode, Others), By Source (Domestic v/s Import), By End User (Hospitals & Clinics, Emergency Medical...
Laryngeal Mask Market Size, Share & Trends Analysis Report By Type (Disposable, Reusable), By Patient (Adult, Children), By End Use (Hospitals & Clinics, ASCs), By Region, And Segment Forecasts, 2020 - 2027
Laryngeal Mask Market Growth & Trends
The global laryngeal mask market size is expected...
The Global Warming Cabinet Market is poised to grow strong during the forecast period 2018 to 2028. Some of the prominent trends that the market is witnessing include growing number of surgical procedures, increasing incidence of chronic diseases, and rising number of COVID-19 patients. Based on the type, the...
The North America Wearable Patch Market would witness market growth of 10.41% CAGR during the forecast period (2020-2026). A wearable patch is alternately called electronic skin or smart patch. They are used to diagnosis, monitor diseases, and drug delivery. It is also helpful in maintaining the health of aging patients suffering from...
Chronic Disease
Cardiovascular Disease
Remote Monitoring
Smoking Cessation
Stroke
North America
United States
Chronic Disease Prevalence
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.